eosinophilic esophagitis

Showing 1 - 25 of 156

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Meta-analysis of Metatrascryptome and Transcriptome of

Not yet recruiting
  • Eosinophilic Esophagitis
  • Formalin-fixed Paraffin-embedded (FFPE) tissue samples analysis
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Oct 2, 2023

French ofQuality of Life Questionnaire for Eosinophilic

Not yet recruiting
  • Eosinophilic Esophagitis
  • Quality of life questionnaire
  • Nice, France
    Hopitaux Pediatriques de Nice Chu-Lenval
Jun 2, 2023

Eosinophilic Esophagitis Trial in Milan (esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal)

Withdrawn
  • Eosinophilic Esophagitis
  • esophagogastroduodenoscopy (EGD), buccal swab, blood withdrawal
  • Milan, Milano, Italy
    IRCCS San Raffaele Hospital
May 31, 2023

Eosinophilic Esophagitis Trial (barzolvolimab, Matching Placebo)

Not yet recruiting
  • Eosinophilic Esophagitis
  • barzolvolimab
  • Matching Placebo
  • (no location specified)
Mar 7, 2023

Eosinophilic Esophagitis Trial in Salt Lake City (NDX-3315)

Recruiting
  • Eosinophilic Esophagitis
  • Salt Lake City, Utah
    University of Utah
Feb 23, 2023

Beetween Allergic Rhinitis and Seasonal EOE Exacerbations

Recruiting
  • Eosinophilic Esophagitis
  • Respiratory Allergy
    • Roma, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Mar 2, 2023

    Eosinophilic Esophagitis Trial in Amsterdam (Intervention)

    Recruiting
    • Eosinophilic Esophagitis
    • Intervention
    • Amsterdam, Netherlands
      Amsterdam UMC, location AMC
    Feb 15, 2023

    Measures in Eosinophilic Gastrointestinal Disorders Across Ages

    Recruiting
    • Eosinophilic Gastrointestinal Disorders (EGIDs)
    • +4 more
      • Rogers, Arkansas
      • +17 more
      Jan 31, 2023

      Eosinophilic Esophagitis Trial in Worldwide (Tezepelumab, Placebo)

      Recruiting
      • Eosinophilic Esophagitis
      • Tezepelumab
      • Placebo
      • Los Angeles, California
      • +95 more
      Jan 27, 2023

      Eosinophilic Esophagitis Trial in Leuven (personalized exclusion diet based on CLE, empiric exclusion diet)

      Recruiting
      • Eosinophilic Esophagitis
      • personalized exclusion diet based on CLE
      • empiric exclusion diet
      • Leuven, Vlaams Brabant, Belgium
        Jan Tack
      Jan 12, 2023

      Eosinophilic Esophagitis Trial in Worldwide (CC-93538, Placebo)

      Recruiting
      • Eosinophilic Esophagitis
      • Birmingham, Alabama
      • +417 more
      Jan 23, 2023

      Eosinophilic Esophagitis, Barrett Esophagus Trial in Boston (SECM capsule)

      Recruiting
      • Eosinophilic Esophagitis
      • Barrett Esophagus
      • SECM capsule
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jan 20, 2023

      Eosinophilic Esophagitis Trial (EP-104IAR)

      Not yet recruiting
      • Eosinophilic Esophagitis
      • (no location specified)
      Jan 16, 2023

      Genetics of Food Allergy and Related Conditions

      Recruiting
      • Food Allergy
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 14, 2023

        Fibrostenotic Eosinophilic Esophagitis: Assessment Tools

        Recruiting
        • Eosinophilic Esophagitis
          • Aurora, Colorado
            Children's Hospital Colorado
          Jan 17, 2023

          Eosinophilic Esophagitis Trial in United States (APT-1011, Placebo oral tablet)

          Recruiting
          • Eosinophilic Esophagitis
          • Colorado Springs, Colorado
          • +4 more
          Jan 4, 2023

          Eosinophilic Esophagitis Trial in Rochester (Baked Milk)

          Enrolling by invitation
          • Eosinophilic Esophagitis
          • Baked Milk
          • Rochester, Minnesota
            Mayo Clinic Minnesota
          Jan 4, 2023

          EoE, Eosinophilic Esophagitis Trial in United States (Mepolizumab 300 mg, Mepolizumab 100 mg, Placebo)

          Completed
          • EoE
          • Eosinophilic Esophagitis
          • Mepolizumab 300 mg
          • +2 more
          • Chicago, Illinois
          • +3 more
          Dec 20, 2022

          Eosinophilic Esophagitis Trial in Jacksonville (Famotidine, Loratadine, Placebo)

          Terminated
          • Eosinophilic Esophagitis
          • Jacksonville, Florida
            Mayo Clinic
          Nov 28, 2022

          Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)

          Active, not recruiting
          • Eosinophilic Esophagitis
          • Birmingham, Alabama
          • +222 more
          Dec 8, 2022

          Eosinophilic Esophagitis Trial in United States (IRL201104, Placebo)

          Completed
          • Eosinophilic Esophagitis
          • Little Rock, Arkansas
          • +22 more
          Dec 7, 2022

          Eosinophilic Esophagitis Trial in Haifa (Else nutrition formula)

          Recruiting
          • Eosinophilic Esophagitis
          • Else nutrition formula
          • Haifa, Israel
            Rambam Health Care Campus
          Nov 14, 2022

          Eosinophilic Esophagitis Trial in Indianapolis, Boston, Melbourne (APT-1011, Placebo oral tablet)

          Completed
          • Eosinophilic Esophagitis
          • Indianapolis, Indiana
          • +2 more
          Nov 13, 2022

          Eosinophilic Esophagitis Trial in Australia, Spain, United States (APT-1011, Placebo oral tablet)

          Completed
          • Eosinophilic Esophagitis
          • Anniston, Alabama
          • +54 more
          Nov 9, 2022

          Eosinophilic Esophagitis Trial in Rozzano (Budesonide Orodispersible Tablets (Jorveza))

          Not yet recruiting
          • Eosinophilic Esophagitis
          • Budesonide Orodispersible Tablets (Jorveza)
          • Rozzano, Milano, Italy
            Department of Gastroenterology, Humanitas Research Hospital
          Oct 21, 2022